A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept Study

Although dengue virus (DENV) affects almost half of the world’s population there are neither preventive treatments nor any long-lasting and protective vaccines available at this time. The complexity of the protective immune response to DENV is still not fully understood. The most advanced vaccine ca...

Full description

Bibliographic Details
Published in:Biomedicines
Main Authors: Alena Reguzova, Nico Fischer, Melanie Müller, Ferdinand Salomon, Thomas Jaenisch, Ralf Amann
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/12/1862